UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)

British journal of cancer, 2006-11, Vol.95 (9), p.1155-1160

2006

Volltextzugriff (PDF)

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Cancer chemotherapy and pharmacology, 2009-09, Vol.64 (4), p.769-775, Article 769

2009

Volltextzugriff (PDF)

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

British journal of cancer, 2007-04, Vol.96 (7), p.1047-1051

2007

Volltextzugriff (PDF)

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

Journal of neuro-oncology, 2008-09, Vol.89 (2), p.179-185

2008

Volltextzugriff (PDF)

Is protracted low-dose temozolomide feasible in glioma patients?

Neurology, 2006-02, Vol.66 (3), p.427-429

2006

Volltextzugriff (PDF)

Criteria of rehabilitation of biotic communities in oil-polluted small rivers (by example of the Shava River, Nizhnii Novgorod oblast)

Inland water biology, 2014, Vol.7 (3), p.192-200

2014

Volltextzugriff (PDF)

2518 POSTER Prolonged maintenance chemotherapy with Temozolomide (TMZ) after concomitant treatment in newly diagnosed GBM: safety profile

European journal of cancer supplements, 2007, Vol.5 (4), p.232-233

2007

Volltextzugriff (PDF)

2507 POSTER Temozolomide (TMZ) concomitant to radiotherapy (RT) plus 12 cycles of maintenance chemotherapy in newly diagnosed GBM: is more better?

European journal of cancer supplements, 2007, Vol.5 (4), p.229-229

2007

Volltextzugriff (PDF)

Glioblastoma in the elderly: Current and future trends

Critical reviews in oncology/hematology, 2006-12, Vol.60 (3), p.256-266

2006

Volltextzugriff (PDF)

Recurrence pattern after concomitant radio-chemotherapy in newly diagnosed glioblastoma patients: Correlation with MGMT promoter methylation status

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2027-2027

2008

Volltextzugriff (PDF)

Should adult medulloblastoma patients at low risk receive adjuvant chemotherapy? Long-term results of a prospective study

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.2018-2018

2007

Volltextzugriff (PDF)

Temozolomide (TMZ) 3 weeks on/1 week off in the treatment of progressive low grade gliomas: A phase II GICNO study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.1514-1514

2006

Volltextzugriff (PDF)

Temozolomide 3 weeks on and I week off as first-line therapy for recurrent glioblastoma : phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)

British journal of cancer, 2006, Vol.95 (9), p.1155-1160

2006

Volltextzugriff (PDF)

Temozolomide (TMZ) for progressive primitive brain tumors: safety at 75 mg/m 2 a day for 21 days every 28: A GICNO (Italian Neuro-Oncology Group) study

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.1541-1541

2005

Volltextzugriff (PDF)

Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1516-1516

2004

Volltextzugriff (PDF)

Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1516-1516

2004

Volltextzugriff (PDF)

VISTA Workers Camp With Patients

Hospital & community psychiatry, 1969-06, Vol.20 (6), p.182-183

Blatt, Vivian M

1969

Volltextzugriff (PDF)

Discrepancy of Signed Measures and Polynomial Approximation

1, 2001

Volltextzugriff (PDF)

Substrate Fed Logic - A Novel Form of Injection Logic

1975 First European Solid State Circuits Conference (ESSCIRC), 1975, p.122-123

1975

Volltextzugriff (PDF)

Present and Future of Bipolar Technologies

ESSCIRC 76: 2nd European Solid State Circuits Conference, 1976, p.VIII-IX

Blatt, V.

1976

Volltextzugriff (PDF)

Session 14 telecommunication circuits

1980 IEEE International Solid-State Circuits Conference. Digest of Technical Papers, 1980, Vol.XXIII, p.169-169

Blatt, V.

1980

Volltextzugriff (PDF)

An I2L 4-Decade Programmable Counter

1975 First European Solid State Circuits Conference (ESSCIRC), 1975, p.22-23

Blatt, V.

1975

Volltextzugriff (PDF)

Schottky IIL /substrate fed logic/ - An analysis of the implications of the vertical injector structure and Schottky collection

IEEE journal of solid-state circuits, 1977-04, Vol.SC-12, p.128-135

1977

Volltextzugriff (PDF)

Conference reports. International solid-state circuits conference

IEE journal on computers and digital techniques, 1979, Vol.2 (3), p.143

1979

Volltextzugriff (PDF)

Schottky I/sup 2/L (substrate fed logic) - An analysis of the implications of the vertical injector structure and Schottky collection

IEEE journal of solid-state circuits, 1977-04, Vol.12 (2), p.128-135

1977

Volltextzugriff (PDF)

1 – 25 von 327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(254)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

Is protracted low-dose temozolomide feasible in glioma patients?

Criteria of rehabilitation of biotic communities in oil-polluted small rivers (by example of the Shava River, Nizhnii Novgorod oblast)

2518 POSTER Prolonged maintenance chemotherapy with Temozolomide (TMZ) after concomitant treatment in newly diagnosed GBM: safety profile

2507 POSTER Temozolomide (TMZ) concomitant to radiotherapy (RT) plus 12 cycles of maintenance chemotherapy in newly diagnosed GBM: is more better?

Glioblastoma in the elderly: Current and future trends

Recurrence pattern after concomitant radio-chemotherapy in newly diagnosed glioblastoma patients: Correlation with MGMT promoter methylation status

Should adult medulloblastoma patients at low risk receive adjuvant chemotherapy? Long-term results of a prospective study

Temozolomide (TMZ) 3 weeks on/1 week off in the treatment of progressive low grade gliomas: A phase II GICNO study

Temozolomide 3 weeks on and I week off as first-line therapy for recurrent glioblastoma : phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)

Temozolomide (TMZ) for progressive primitive brain tumors: safety at 75 mg/m 2 a day for 21 days every 28: A GICNO (Italian Neuro-Oncology Group) study

Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group)

Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group)

VISTA Workers Camp With Patients

Discrepancy of Signed Measures and Polynomial Approximation

Substrate Fed Logic - A Novel Form of Injection Logic

Present and Future of Bipolar Technologies

Session 14 telecommunication circuits

An I2L 4-Decade Programmable Counter

Schottky IIL /substrate fed logic/ - An analysis of the implications of the vertical injector structure and Schottky collection

Conference reports. International solid-state circuits conference

Schottky I/sup 2/L (substrate fed logic) - An analysis of the implications of the vertical injector structure and Schottky collection

Suchergebnisse filtern